Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

February 4, 2025
Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocksMizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
Share This

Jared Holz, Mizuho Securities America healthcare sector strategist, joins ‘Squawk Box’ to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and more.

Latest Mizuho News

The winner of the OpenAI-Anthropic race may not be the first to the IPO finish line

The winner of the OpenAI-Anthropic race may not be the first to the IPO finish line

June 9, 2026
Mizuho Americas wins five FCS Portfolio Awards

Mizuho Americas wins five FCS Portfolio Awards

May 20, 2026
Mizuho Head of Investment: AI is imacting every sector in the global economy

Mizuho Head of Investment: AI is imacting every sector in the global economy

June 9, 2026

Mizuho news from around the globe

back-to-top-blue